Skip to main content
Signal8

Biomind Labs Inc. (BMNDF)

Sector: Biotechnology

Industry: Biotechnology

Biomind Labs Inc. logo

Biomind Labs Inc.

OTC:BMNDFHealthcare
-13.95%$0.2153
CLOSED
Mkt Cap$16.7M
EV-
Float49.41M
O/S77.57M
VOL250 sh
$ Vol$54
RVOL0.22×
Inst Own-
Net Cash/Sh-
Dilution
Biomind Labs Inc. logoOTC:BMNDFClosed$0.2153-13.95%
Historical Data
DateOpenHighLowCloseVolume
Nov 12, 20260.21530.21530.21530.2153250
Oct 21, 20260.25250.25250.25020.25021,999
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About

Biomind Labs Inc. operates as a biotechnology firm dedicated to advancing innovative pharmaceutical therapies and sophisticated nanotech drug delivery mechanisms, primarily addressing a range of psychiatric and neurological disorders. Among its leading pipeline assets, BMND01 is currently in Phase II clinical trials for treating depression. Another key candidate, BMND08, a derivative of 5-Methoxy-N,N-dimethyltryptamine, is also in Phase II trials, addressing depression and anxiety specifically in patients experiencing cognitive decline associated with Alzheimer's disease.

The company's broader development portfolio includes early-stage and preclinical candidates such as BMND02 for fibromyalgia, BMND03 for substance use disorders, BMND05 for persistent pain management, BMND06 for inflammatory conditions, and BMND07 for severe clinical depression. Biomind Labs Inc. maintains its headquarters in Canelones, Uruguay.

Key Metrics
Market Cap$16.70M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 77.57M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryCACA
IPO Date-
Shares Outstanding77.57M
Authorized Shares
Float49.41M
52-Week Range
$0.0110$0.8000
$0.2153(26th percentile)
Volume
Average Daily Volume1.13K
250 today vs 1.13K avg(-78%)

30d Avg

1.13K

60d Avg

3.72K

90d Avg

3.42K

Earnings
Dividend History
No dividend history available

Biomind Labs Inc. (OTC: BMNDF) traded at $0.2153 on Nov 12, 2026, down 13.95% from the previous close of $0.2502. 52-week range: $0.0110 to $0.8000. The company is in the Healthcare sector (Biotechnology).